Bruker Corporation (BRKR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $9.41B
Last updated: Nov 17, 2026 at 11:05 AM ET
Bruker Corporation (BRKR) P/E Ratio & Valuation History
Bruker (BRKR) trades at 31.1x trailing earnings and 2.6x sales. Its P/E of 31.1x is above its 5-year median of 27.3x. Its forward P/E is 13.8x. The median P/E across 9 similar companies is 23.8x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 125.4% higher over the next year. Its free cash flow yield is 2.6%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 31.1x |
| Forward P/E | 13.8x |
| Price to sales | 2.6x |
| EV/EBITDA | 68.8x |
| Price to FCF | 37.8x |
| EV/FCF | 44.3x |
| PEG | 1.5 |
| FCF yield | 2.6% |
Historical Medians
Against its 10-year medians, its P/E is 12.7% above 27.6x and its P/S is 7.1% below 2.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 31.1x | 27.3x | 27.6x |
| P/S | 2.6x | 3.2x | 2.8x |
| P/B | N/A | N/A | 7.4x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 17.8x in 2016 to 40.1x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $47.11 | 25.7x | 2.1x | 2.9x |
| 2024 | $58.62 | 24.3x | 2.6x | 5.0x |
| 2023 | $73.48 | 28.5x | 3.6x | 7.8x |
| 2022 | $68.35 | 29.2x | 4.0x | 9.1x |
| 2021 | $83.91 | 40.0x | 5.3x | 12.0x |
| 2020 | $54.13 | 40.1x | 4.2x | 8.7x |
| 2019 | $50.97 | 32.5x | 1.9x | 8.7x |
| 2018 | $29.77 | 21.3x | 2.5x | 5.2x |
| 2017 | $34.32 | 28.1x | 3.1x | 7.3x |
| 2016 | $21.18 | 17.8x | 2.1x | 4.9x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BRKR
What is BRKR's forward P/E ratio?
Bruker has a forward P/E ratio of 13.8x.
Is BRKR stock overvalued?
GNG's valuation label for BRKR is Undervalued. Its P/E of 31.1x compares with a median of 23.8x across 9 similar companies.
What is BRKR's price to sales ratio?
Bruker has a price to sales ratio of 2.6x.
What is Bruker's average P/E ratio over 5 years?
Bruker's median P/E over the last 5 years is 27.3x, from 60 month-end values through Oct 2026.
What is BRKR's PEG ratio?
Bruker has a PEG ratio of 1.5.
BRKR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts